ELVN Exercise Disclosure
Hohl Benjamin · SEC Form 4 · Filed Oct 21, 2026
Exercise
Calculated transaction value
$89.37K
Hohl Benjamin Chief Financial Officer
ELVN
Enliven Therapeutics
ELVN
Transaction date
Oct 19, 2026
Public filing date
Oct 21, 2026
Filing lag
Filed 2 days later
ELVN daily price context
Close on/before transaction
$38.7
Oct 19, 2026
First close after public filing
$41.93
Oct 22, 2026
Return after filing · so far
+20.55%
Through Nov 10, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 6,018 shares @ $14.85
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001882764-26-000009
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$320.91K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enliven Therapeutics, Inc. ELVN Current | Exercise | Oct 19, 2026 | $89.37K |
| Enliven Therapeutics, Inc. ELVN | Sale | Oct 19, 2026 | $231.55K |
| Enliven Therapeutics, Inc. ELVN | Exercise | Oct 19, 2026 | $0 |